Furthermore, OA could directly inhibit the expression of the SREBP-1 protein and decrease fatty acid accumulation in the body, thus ameliorating the progress of nonalcoholic fatty liver [63]. This evidence concerns the gene SREBF1 and non-alcoholic fatty liver.